Pages that link to "Q88801926"

The following pages link to The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice (Q88801926):

Displaying 9 items.

• The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health (Q58719667) (← links)
• The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release (Q64108732) (← links)
• Bi-directional drug-microbiome interactions of anti-diabetics (Q90555954) (← links)
• The Janus Face of Cereals: Wheat-Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High-Fat/High-Sucrose Diet (Q90684083) (← links)
• Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis (Q92685749) (← links)
• Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice (Q92845413) (← links)
• Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics (Q93159949) (← links)
• The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study (Q99549054) (← links)
• Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression (Q101564256) (← links)